# Trial of Pegasys® in Patients With Chronic Hepatitis C

> **NCT00245414** · PHASE4 · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 108 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pegasys®
- **DRUG:** Pegasys®

## Key facts

- **NCT ID:** NCT00245414
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2010-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245414, "Trial of Pegasys® in Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00245414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*